Targeting CD137 enhances the efficacy of cetuximab. - Université de Rennes Access content directly
Journal Articles Journal of Clinical Investigation Year : 2014

Targeting CD137 enhances the efficacy of cetuximab.

Abstract

Treatment with cetuximab, an EGFR-targeting IgG1 mAb, results in beneficial, yet limited, clinical improvement for patients with head and neck (HN) cancer as well as colorectal cancer (CRC) patients with WT KRAS tumors. Antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells contributes to the efficacy of cetuximab. The costimulatory molecule CD137 (4-1BB) is expressed following NK and memory T cell activation. We found that isolated human NK cells substantially increased expression of CD137 when exposed to cetuximab-coated, EGFR-expressing HN and CRC cell lines. Furthermore, activation of CD137 with an agonistic mAb enhanced NK cell degranulation and cytotoxicity. In multiple murine xenograft models, including EGFR-expressing cancer cells, HN cells, and KRAS-WT and KRAS-mutant CRC, combined cetuximab and anti-CD137 mAb administration was synergistic and led to complete tumor resolution and prolonged survival, which was dependent on the presence of NK cells. In patients receiving cetuximab, the level of CD137 on circulating and intratumoral NK cells was dependent on postcetuximab time and host FcyRIIIa polymorphism. Interestingly, the increase in CD137-expressing NK cells directly correlated to an increase in EGFR-specific CD8+ T cells. These results support development of a sequential antibody approach against EGFR-expressing malignancies that first targets the tumor and then the host immune system.
Fichier principal
Vignette du fichier
render.pdf (1.7 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-01021651 , version 1 (09-07-2014)

Identifiers

Cite

Holbrook E Kohrt, a Dimitrios Colevas, Roch Houot, Kipp Weiskopf, Matthew J Goldstein, et al.. Targeting CD137 enhances the efficacy of cetuximab.. Journal of Clinical Investigation, 2014, 124 (6), pp.2668-82. ⟨10.1172/JCI73014⟩. ⟨hal-01021651⟩
622 View
432 Download

Altmetric

Share

Gmail Facebook X LinkedIn More